Healthcare - Biotechnology - NASDAQ - US
$ 34.17
-9.34 %
$ 1.89 B
Market Cap
-15.05
P/E
Price Target
Average
170.41%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
0.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Structure Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for GPCR of $92.4 , with forecasts ranging from a low of $65 to a high of $118 .
GPCR Lowest Price Target
Wall Street Target
65 USD
90.23%
GPCR Average Price Target
Wall Street Target
92.4 USD
170.41%
GPCR Highest Price Target
Wall Street Target
118 USD
245.33%
REVENUE FORECAST
Revenue Forecast Chart GPCR
EBIT FORECAST
EBIT Forecast Chart GPCR
NET INCOME FORECAST
Net Income Chart GPCR